{"pmid":32267531,"title":"COVID-19 Obstetrics Task Force, Lombardy, Italy: executive management summary and short report of outcome.","text":["COVID-19 Obstetrics Task Force, Lombardy, Italy: executive management summary and short report of outcome.","From February 24, 2020, a COVID-19 obstetric task force was structured to deliver management recommendations for obstetric care. From March 1, 2020, six COVID-19 hubs and their spokes were designated. An interim analysis of cases occurring in or transferred to these hubs was performed on March 20, 2020 and recommendations were released on March 24, 2020. The vision of this strict organization was to centralize patients in high-risk maternity centers in order to concentrate human resources and personal protective equipment (PPE), dedicate protected areas of these major hospitals, and centralize clinical multidisciplinary experience with this disease. All maternity hospitals were informed to provide a protected labor and delivery room for nontransferable patients in advanced labor. A pre-triage based on temperature and 14 other items was developed in order to screen suspected patients in all hospitals to be tested with nasopharyngeal swabs. Obstetric outpatient facilities were instructed to maintain scheduled pregnancy screening as per Italian guidelines, and to provide pre-triage screening and surgical masks for personnel and patients for pre-triage-negative patients. Forty-two cases were recorded in the first 20 days of hub and spoke organization. The clinical presentation was interstitial pneumonia in 20 women. Of these, seven required respiratory support and eventually did well. Two premature labors occurred.","Int J Gynaecol Obstet","Ferrazzi, Enrico M","Frigerio, Luigi","Cetin, Irene","Vergani, Patrizia","Spinillo, Arsenio","Prefumo, Federico","Pellegrini, Edda","Gargantini, Gianluigi","32267531"],"abstract":["From February 24, 2020, a COVID-19 obstetric task force was structured to deliver management recommendations for obstetric care. From March 1, 2020, six COVID-19 hubs and their spokes were designated. An interim analysis of cases occurring in or transferred to these hubs was performed on March 20, 2020 and recommendations were released on March 24, 2020. The vision of this strict organization was to centralize patients in high-risk maternity centers in order to concentrate human resources and personal protective equipment (PPE), dedicate protected areas of these major hospitals, and centralize clinical multidisciplinary experience with this disease. All maternity hospitals were informed to provide a protected labor and delivery room for nontransferable patients in advanced labor. A pre-triage based on temperature and 14 other items was developed in order to screen suspected patients in all hospitals to be tested with nasopharyngeal swabs. Obstetric outpatient facilities were instructed to maintain scheduled pregnancy screening as per Italian guidelines, and to provide pre-triage screening and surgical masks for personnel and patients for pre-triage-negative patients. Forty-two cases were recorded in the first 20 days of hub and spoke organization. The clinical presentation was interstitial pneumonia in 20 women. Of these, seven required respiratory support and eventually did well. Two premature labors occurred."],"journal":"Int J Gynaecol Obstet","authors":["Ferrazzi, Enrico M","Frigerio, Luigi","Cetin, Irene","Vergani, Patrizia","Spinillo, Arsenio","Prefumo, Federico","Pellegrini, Edda","Gargantini, Gianluigi"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32267531","week":"202015|Apr 06 - Apr 12","doi":"10.1002/ijgo.13162","keywords":["COVID-19","SARS-CoV-2","pregnancy"],"source":"PubMed","locations":["Italian","Italy","Lombardy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1663609715843661824,"score":7.9164424,"similar":[{"pmid":32276282,"title":"Protecting Labor and Delivery Personnel from COVID-19 during the Second Stage of Labor.","text":["Protecting Labor and Delivery Personnel from COVID-19 during the Second Stage of Labor.",". Second stage of labor exposes providers to aerosol.. . COVID-19 risk during second stage of labor is high.. . N95 should be used during second stage of labor.. The novel coronavirus disease 2019 (COVID-19) is spreading fast and is affecting the clinical workers at much higher risk than the general population. Little is known about COVID-19 effect on pregnant women; however, the emerging evidence suggests they may be at high risk of asymptomatic disease. In light of projected shortage of personal protective equipment (PPE), there is an aggressive attempt at conservation. In obstetrics, the guidelines on PPE use are controversial and differ among hospitals, globally, as well as nationally. The centers for disease control and prevention (CDC) recommend using N95 respirators, which are respirators that offer a higher level of protection instead of a facemask for when performing or present for an aerosol-generating procedures (AGP). However, the second stage of labor is not considered an AGP. The second stage of labor can last up to 4 hours. During that time, labor and delivery personnel is in close contact to patients, who are exerting extreme effort during and frequently blow out their breath, cough, shout, and vomit, all of which put the health care team at risk, considering that COVID-19 transmission occurs through aerosol generated by coughing and sneezing. The CDC and the American College of Obstetricians and Gynecologists (ACOG) do not provide clarification on the use of N95 during the second stage. We recommend that labor and delivery personnel have the utmost caution and be granted the protection they need to protect themselves and other patients. This includes providing labor and delivery personnel full PPE including N95 for the second stage of labor. This is critical to ensure the adequate protection for health care workers and to prevent spread to other health care workers and patients.","Am J Perinatol","Palatnik, Anna","McIntosh, Jennifer J","32276282"],"abstract":[". Second stage of labor exposes providers to aerosol.. . COVID-19 risk during second stage of labor is high.. . N95 should be used during second stage of labor.. The novel coronavirus disease 2019 (COVID-19) is spreading fast and is affecting the clinical workers at much higher risk than the general population. Little is known about COVID-19 effect on pregnant women; however, the emerging evidence suggests they may be at high risk of asymptomatic disease. In light of projected shortage of personal protective equipment (PPE), there is an aggressive attempt at conservation. In obstetrics, the guidelines on PPE use are controversial and differ among hospitals, globally, as well as nationally. The centers for disease control and prevention (CDC) recommend using N95 respirators, which are respirators that offer a higher level of protection instead of a facemask for when performing or present for an aerosol-generating procedures (AGP). However, the second stage of labor is not considered an AGP. The second stage of labor can last up to 4 hours. During that time, labor and delivery personnel is in close contact to patients, who are exerting extreme effort during and frequently blow out their breath, cough, shout, and vomit, all of which put the health care team at risk, considering that COVID-19 transmission occurs through aerosol generated by coughing and sneezing. The CDC and the American College of Obstetricians and Gynecologists (ACOG) do not provide clarification on the use of N95 during the second stage. We recommend that labor and delivery personnel have the utmost caution and be granted the protection they need to protect themselves and other patients. This includes providing labor and delivery personnel full PPE including N95 for the second stage of labor. This is critical to ensure the adequate protection for health care workers and to prevent spread to other health care workers and patients."],"journal":"Am J Perinatol","authors":["Palatnik, Anna","McIntosh, Jennifer J"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32276282","week":"202015|Apr 06 - Apr 12","doi":"10.1055/s-0040-1709689","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1663712077933445120,"score":317.46478},{"pmid":32265365,"title":"Obstetric Anesthesia During the COVID-19 Pandemic.","text":["Obstetric Anesthesia During the COVID-19 Pandemic.","With increasing numbers of Coronavirus Disease 2019 (COVID 19) cases due to efficient human-to-human transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the United States, preparation for the unpredictable setting of labor and delivery is paramount. The priorities are two-fold in the management of obstetric patients with COVID-19 infection or persons under investigation (PUI): (1) caring for the range of asymptomatic to critically ill pregnant and postpartum women; (2) protecting health care workers and beyond from exposure during the delivery hospitalization (health care providers, personnel, family members). The goal of this review is to provide evidence-based recommendations, or expert opinion when evidence is limited, for anesthesiologists caring for pregnant women during the COVID 19 pandemic, with a focus on preparedness and best clinical obstetric anesthesia practice.","Anesth Analg","Bauer, Melissa","Bernstein, Kyra","Dinges, Emily","Delgado, Carlos","El-Sharawi, Nadir","Sultan, Pervez","Mhyre, Jill M","Landau, Ruth","32265365"],"abstract":["With increasing numbers of Coronavirus Disease 2019 (COVID 19) cases due to efficient human-to-human transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the United States, preparation for the unpredictable setting of labor and delivery is paramount. The priorities are two-fold in the management of obstetric patients with COVID-19 infection or persons under investigation (PUI): (1) caring for the range of asymptomatic to critically ill pregnant and postpartum women; (2) protecting health care workers and beyond from exposure during the delivery hospitalization (health care providers, personnel, family members). The goal of this review is to provide evidence-based recommendations, or expert opinion when evidence is limited, for anesthesiologists caring for pregnant women during the COVID 19 pandemic, with a focus on preparedness and best clinical obstetric anesthesia practice."],"journal":"Anesth Analg","authors":["Bauer, Melissa","Bernstein, Kyra","Dinges, Emily","Delgado, Carlos","El-Sharawi, Nadir","Sultan, Pervez","Mhyre, Jill M","Landau, Ruth"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32265365","week":"202015|Apr 06 - Apr 12","doi":"10.1213/ANE.0000000000004856","source":"PubMed","locations":["United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention","Treatment"],"weight":1,"_version_":1663609715751387136,"score":305.26743},{"pmid":32196655,"title":"Expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus (COVID-19) infection.","text":["Expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus (COVID-19) infection.","OBJECTIVE: To provide clinical management guidelines for novel coronavirus (COVID-19) in pregnancy. METHODS: On February 5, 2020, a multidisciplinary teleconference comprising Chinese physicians and researchers was held and medical management strategies of COVID-19 infection in pregnancy were discussed. RESULTS: Ten key recommendations were provided for the management of COVID-19 infections in pregnancy. CONCLUSION: Currently, there is no clear evidence regarding optimal delivery timing, the safety of vaginal delivery, or whether cesarean delivery prevents vertical transmission at the time of delivery; therefore, route of delivery and delivery timing should be individualized based on obstetrical indications and maternal-fetal status.","Int J Gynaecol Obstet","Chen, Dunjin","Yang, Huixia","Cao, Yun","Cheng, Weiwei","Duan, Tao","Fan, Cuifang","Fan, Shangrong","Feng, Ling","Gao, Yuanmei","He, Fang","He, Jing","Hu, Yali","Jiang, Yi","Li, Yimin","Li, Jiafu","Li, Xiaotian","Li, Xuelan","Lin, Kangguang","Liu, Caixia","Liu, Juntao","Liu, Xinghui","Pan, Xingfei","Pang, Qiumei","Pu, Meihua","Qi, Hongbo","Shi, Chunyan","Sun, Yu","Sun, Jingxia","Wang, Xietong","Wang, Yichun","Wang, Zilian","Wang, Zhijian","Wang, Cheng","Wu, Suqiu","Xin, Hong","Yan, Jianying","Zhao, Yangyu","Zheng, Jun","Zhou, Yihua","Zou, Li","Zeng, Yingchun","Zhang, Yuanzhen","Guan, Xiaoming","32196655"],"abstract":["OBJECTIVE: To provide clinical management guidelines for novel coronavirus (COVID-19) in pregnancy. METHODS: On February 5, 2020, a multidisciplinary teleconference comprising Chinese physicians and researchers was held and medical management strategies of COVID-19 infection in pregnancy were discussed. RESULTS: Ten key recommendations were provided for the management of COVID-19 infections in pregnancy. CONCLUSION: Currently, there is no clear evidence regarding optimal delivery timing, the safety of vaginal delivery, or whether cesarean delivery prevents vertical transmission at the time of delivery; therefore, route of delivery and delivery timing should be individualized based on obstetrical indications and maternal-fetal status."],"journal":"Int J Gynaecol Obstet","authors":["Chen, Dunjin","Yang, Huixia","Cao, Yun","Cheng, Weiwei","Duan, Tao","Fan, Cuifang","Fan, Shangrong","Feng, Ling","Gao, Yuanmei","He, Fang","He, Jing","Hu, Yali","Jiang, Yi","Li, Yimin","Li, Jiafu","Li, Xiaotian","Li, Xuelan","Lin, Kangguang","Liu, Caixia","Liu, Juntao","Liu, Xinghui","Pan, Xingfei","Pang, Qiumei","Pu, Meihua","Qi, Hongbo","Shi, Chunyan","Sun, Yu","Sun, Jingxia","Wang, Xietong","Wang, Yichun","Wang, Zilian","Wang, Zhijian","Wang, Cheng","Wu, Suqiu","Xin, Hong","Yan, Jianying","Zhao, Yangyu","Zheng, Jun","Zhou, Yihua","Zou, Li","Zeng, Yingchun","Zhang, Yuanzhen","Guan, Xiaoming"],"date":"2020-03-21T11:00:00Z","year":2020,"_id":"32196655","week":"202012|Mar 16 - Mar 22","doi":"10.1002/ijgo.13146","keywords":["COVID-19","Expert consensus","Management guidelines","Neonates","Pregnant women"],"source":"PubMed","locations":["Chinese"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1663352133511020544,"score":297.7332},{"pmid":32217113,"title":"Coronavirus Disease 2019 (COVID-19) Pandemic and Pregnancy.","text":["Coronavirus Disease 2019 (COVID-19) Pandemic and Pregnancy.","The current coronavirus disease 2019 (COVID-19) pneumonia pandemic, caused by the severe acute respiratory syndrome 2 (SARS-CoV-2) virus, is spreading globally at an accelerated rate, with a basic reproduction number (R0) of 2 - 2.5, indicating that 2 - 3 persons will be infected from an index patient. A serious public health emergency, it is particularly deadly in vulnerable populations and communities in which healthcare providers are insufficiently prepared to manage the infection. As of March 16, 2020, there are more than 180,000 confirmed cases of COVID-19 worldwide, with over 7,000 related deaths. The SARS-CoV-2 virus has been isolated from asymptomatic individuals, and affected patients continue to be infectious two weeks after cessation of symptoms. The substantial morbidity and socioeconomic impact have necessitated drastic measures across all continents, including nationwide lockdowns and border closures. Pregnant women and their fetuses represent a high-risk population during infectious disease outbreaks. To date, the outcomes of 55 pregnant women infected with COVID-19 and 46 neonates have been reported in the literature, with no definite evidence of vertical transmission. Physiological and mechanical changes in pregnancy increase susceptibility to infections in general, particularly when the cardiorespiratory system is affected, and encourage rapid progression to respiratory failure in the gravida. Furthermore, the pregnancy bias towards T-helper 2 (Th2) system dominance which protects the fetus, leaves the mother vulnerable to viral infections, which are more effectively contained by the Th1 system. These unique challenges mandate an integrated approach to pregnancies affected by SARS-CoV-2. Here we present a review of COVID-19 in pregnancy, bringing together the various factors integral to the understanding of pathophysiology and susceptibility, diagnostic challenges with real-time reverse transcriptase polymerase chain reaction (RT-PCR) assays, therapeutic controversies, intrauterine transmission and maternal-fetal complications. We discuss the latest options in antiviral therapy and vaccine development, including the novel use of chloroquine in the management of COVID-19. Fetal surveillance, in view of the predisposition to growth restriction and special considerations during labor and delivery are addressed. Additionally, we focus on keeping frontline obstetric care providers safe while continuing to provide essential services. Our clinical service model is built around the principles of workplace segregation, responsible social distancing, containment of cross-infection to healthcare providers, judicious use of personal protective equipment and telemedicine. Our aim is to share a framework which can be adopted by tertiary maternity units managing pregnant women in the flux of a pandemic while maintaining the safety of the patient and healthcare provider at its core.","Am J Obstet Gynecol","Dashraath, Pradip","Jing Lin Jeslyn, Wong","Mei Xian Karen, Lim","Li Min, Lim","Sarah, Li","Biswas, Arijit","Arjandas Choolani, Mahesh","Mattar, Citra","Lin, Su Lin","32217113"],"abstract":["The current coronavirus disease 2019 (COVID-19) pneumonia pandemic, caused by the severe acute respiratory syndrome 2 (SARS-CoV-2) virus, is spreading globally at an accelerated rate, with a basic reproduction number (R0) of 2 - 2.5, indicating that 2 - 3 persons will be infected from an index patient. A serious public health emergency, it is particularly deadly in vulnerable populations and communities in which healthcare providers are insufficiently prepared to manage the infection. As of March 16, 2020, there are more than 180,000 confirmed cases of COVID-19 worldwide, with over 7,000 related deaths. The SARS-CoV-2 virus has been isolated from asymptomatic individuals, and affected patients continue to be infectious two weeks after cessation of symptoms. The substantial morbidity and socioeconomic impact have necessitated drastic measures across all continents, including nationwide lockdowns and border closures. Pregnant women and their fetuses represent a high-risk population during infectious disease outbreaks. To date, the outcomes of 55 pregnant women infected with COVID-19 and 46 neonates have been reported in the literature, with no definite evidence of vertical transmission. Physiological and mechanical changes in pregnancy increase susceptibility to infections in general, particularly when the cardiorespiratory system is affected, and encourage rapid progression to respiratory failure in the gravida. Furthermore, the pregnancy bias towards T-helper 2 (Th2) system dominance which protects the fetus, leaves the mother vulnerable to viral infections, which are more effectively contained by the Th1 system. These unique challenges mandate an integrated approach to pregnancies affected by SARS-CoV-2. Here we present a review of COVID-19 in pregnancy, bringing together the various factors integral to the understanding of pathophysiology and susceptibility, diagnostic challenges with real-time reverse transcriptase polymerase chain reaction (RT-PCR) assays, therapeutic controversies, intrauterine transmission and maternal-fetal complications. We discuss the latest options in antiviral therapy and vaccine development, including the novel use of chloroquine in the management of COVID-19. Fetal surveillance, in view of the predisposition to growth restriction and special considerations during labor and delivery are addressed. Additionally, we focus on keeping frontline obstetric care providers safe while continuing to provide essential services. Our clinical service model is built around the principles of workplace segregation, responsible social distancing, containment of cross-infection to healthcare providers, judicious use of personal protective equipment and telemedicine. Our aim is to share a framework which can be adopted by tertiary maternity units managing pregnant women in the flux of a pandemic while maintaining the safety of the patient and healthcare provider at its core."],"journal":"Am J Obstet Gynecol","authors":["Dashraath, Pradip","Jing Lin Jeslyn, Wong","Mei Xian Karen, Lim","Li Min, Lim","Sarah, Li","Biswas, Arijit","Arjandas Choolani, Mahesh","Mattar, Citra","Lin, Su Lin"],"date":"2020-03-29T11:00:00Z","year":2020,"_id":"32217113","week":"202013|Mar 23 - Mar 29","doi":"10.1016/j.ajog.2020.03.021","keywords":["COVID-19","MERS-CoV","SARS-CoV","SARS-CoV-2","antiviral","baricitinib","chloroquine","coronavirus","fever","mask","morbidity","mortality","obstetric management","pandemic","pregnancy","remdesivir","respiratory distress syndrome","respiratory failure","sepsis","susceptibility","virus"],"source":"PubMed","topics":["Treatment","Prevention"],"weight":1,"e_drugs":["Chloroquine"],"_version_":1663352135062913025,"score":283.3034},{"pmid":32195699,"title":"Perioperative Management of Patients Infected with the Novel Coronavirus: Recommendation from the Joint Task Force of the Chinese Society of Anesthesiology and the Chinese Association of Anesthesiologists.","text":["Perioperative Management of Patients Infected with the Novel Coronavirus: Recommendation from the Joint Task Force of the Chinese Society of Anesthesiology and the Chinese Association of Anesthesiologists.","The outbreak of the new Coronavirus disease, COVID-19, has been involved in 77,262 cases in China as well as in 27 other countries as of February 24, 2020. Because the virus is novel to human beings, and there is no vaccine yet available, every individual is susceptible and can become infected. Healthcare workers are at high risk, and unfortunately, more than 3,000 healthcare workers in China have been infected. Anesthesiologists are among healthcare workers who are at an even higher risk of becoming infected because of their close contact with infected patients and high potential of exposure to respiratory droplets or aerosol from their patients' airways. In order to provide healthcare workers with updated recommendations on the management of patients in the perioperative setting as well as for emergency airway management outside of the operating room, the two largest anesthesia societies, the Chinese Society of Anesthesiology (CSA) and the Chinese Association of Anesthesiologists (CAA) have formed a task force to produce the recommendations. The task force hopes to help healthcare workers, particularly anesthesiologists, optimize the care of their patients and protect patients, healthcare workers, and the public from becoming infected. The recommendations were created mainly based on the practice and experience of anesthesiologists who provide care to patients in China. Therefore, adoption of these recommendations outside of China must be done with caution, and the local environment, culture, uniqueness of the healthcare system, and patients' needs should be considered. The task force will continuously update the recommendations and incorporate new information in future versions.","Anesthesiology","Chen, Xiangdong","Liu, Yanhong","Gong, Yahong","Guo, Xiangyang","Zuo, Mingzhang","Li, Jun","Shi, Wenzhu","Li, Hao","Xu, Xiaohan","Mi, Weidong","Huang, Yuguang","32195699"],"abstract":["The outbreak of the new Coronavirus disease, COVID-19, has been involved in 77,262 cases in China as well as in 27 other countries as of February 24, 2020. Because the virus is novel to human beings, and there is no vaccine yet available, every individual is susceptible and can become infected. Healthcare workers are at high risk, and unfortunately, more than 3,000 healthcare workers in China have been infected. Anesthesiologists are among healthcare workers who are at an even higher risk of becoming infected because of their close contact with infected patients and high potential of exposure to respiratory droplets or aerosol from their patients' airways. In order to provide healthcare workers with updated recommendations on the management of patients in the perioperative setting as well as for emergency airway management outside of the operating room, the two largest anesthesia societies, the Chinese Society of Anesthesiology (CSA) and the Chinese Association of Anesthesiologists (CAA) have formed a task force to produce the recommendations. The task force hopes to help healthcare workers, particularly anesthesiologists, optimize the care of their patients and protect patients, healthcare workers, and the public from becoming infected. The recommendations were created mainly based on the practice and experience of anesthesiologists who provide care to patients in China. Therefore, adoption of these recommendations outside of China must be done with caution, and the local environment, culture, uniqueness of the healthcare system, and patients' needs should be considered. The task force will continuously update the recommendations and incorporate new information in future versions."],"journal":"Anesthesiology","authors":["Chen, Xiangdong","Liu, Yanhong","Gong, Yahong","Guo, Xiangyang","Zuo, Mingzhang","Li, Jun","Shi, Wenzhu","Li, Hao","Xu, Xiaohan","Mi, Weidong","Huang, Yuguang"],"date":"2020-03-21T11:00:00Z","year":2020,"_id":"32195699","week":"202012|Mar 16 - Mar 22","doi":"10.1097/ALN.0000000000003301","source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Prevention"],"weight":1,"_version_":1663352133551915009,"score":273.44345}]}